ホーム › 急性骨髄性白血病 › カリフォルニア州 › Baldwin Park
Baldwin Park、CAにおける急性骨髄性白血病の臨床試験
Baldwin Parkとその周辺地域（約30マイル以内）の拠点で、急性骨髄性白血病に関する40件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
A Study to Assess Adverse Events and Change in Disease Activity When Intravenous (IV) Pivekimab Sunirine is Given in Combination With Oral Venetoclax and IV or Subcutaneous Azacitidine in Adult Participants With Acute Myeloid Leukemia (AML)
被験者募集中第2/3相
- City of Hope National Medical Center /ID# 279568, Duarte · 4マイル先
A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
被験者募集中第1相
- City of Hope, Duarte · 4マイル先
A Phase 1 Study of AOH1996 in Patients With Relapsed/Refractory Acute Myeloid Leukemia
被験者募集中第1相
- City of Hope Medical Center, Duarte · 4マイル先
Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation
被験者募集中第3相
- Clinical Trial Site, Duarte · 4マイル先
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
被験者募集中第3相
- City of Hope, Duarte · 4マイル先
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
被験者募集中第3相
- City of Hope Comprehensive Cancer Center, Duarte · 4マイル先
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
被験者募集中第2相
- City of Hope Comprehensive Cancer Center, Duarte · 4マイル先
Phase 1 Study of AUTX-703 in Relapsed/Refractory AML and MDS
被験者募集中第1相
- City of Hope National Medical Center, Duarte · 4マイル先
The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell Transplantation
被験者募集中第1/2相健康なボランティア歓迎
- City of Hope, Duarte · 4マイル先
A Study to Assess the Safety, Tolerability, and Antileukemic Activity of Debio 1562M in Participants With Acute Myeloid Leukemia (AML)
被験者募集中第1/2相
- City of Hope Comprehensive Cancer Center, Duarte · 4マイル先
Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML
被験者募集中第1/2相
- City of Hope National Medical Center, Duarte · 4マイル先
MiRisten for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
被験者募集中第1相
- City of Hope Medical Center, Duarte · 4マイル先
Eganelisib as Monotherapy and in Combination With Cytarabine in Relapsed/Refractory AML
被験者募集中第1相
- City of Hope, Duarte · 4マイル先
8-Chloroadenosine in Combination With Venetoclax for the Treatment of Patients With Relapsed/Refractory Acute Myeloid Leukemia
被験者募集中第1相
- City of Hope Medical Center, Duarte · 4マイル先
Individualized AML Treatment
被験者募集中観察研究
- City of Hope Medical Center, Duarte · 4マイル先
Total Marrow and Lymphoid Irradiation in Combination With Fludarabine and Melphalan as Conditioning for Allogeneic Peripheral Blood Stem Cell Hematopoietic Cell Transplant in Older Patients With Refractory and Relapsed Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome
被験者募集中第2相
- City of Hope Medical Center, Duarte · 4マイル先
225Ac-DOTA-Anti-CD38 Daratumumab Monoclonal Antibody With Fludarabine, Melphalan and Total Marrow and Lymphoid Irradiation as Conditioning Treatment for Donor Stem Cell Transplant in Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Myelodysplastic Syndrome
被験者募集中第1相
- City of Hope Medical Center, Duarte · 4マイル先
A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant
被験者募集中第1相健康なボランティア歓迎
- City of Hope Medical Center, Duarte · 4マイル先
Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT
被験者募集中第3相
- City of Hope Comprehensive Cancer Center - Duarte, Duarte · 4マイル先
Tagraxofusp and Azacitidine for Maintenance Treatment in Patients With CD123 Positive AML and MDS Following Donor Hematopoietic Cell Transplant
被験者募集中第1相
- City of Hope Medical Center, Duarte · 4マイル先
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
被験者募集中観察研究
- City of Hope, Duarte · 4マイル先
Emapalumab With Post-Transplant Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Graft-versus-Host Disease After Donor Reduced-Intensity Hematopoietic Cell Transplant
被験者募集中第1相
- City of Hope Medical Center, Duarte · 4マイル先
Vedolizumab Plus Post-transplant Cyclophosphamide and Short Course Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Reduced Intensity Conditioning
被験者募集中第2相
- City of Hope Medical Center, Duarte · 4マイル先
A Study of Revumenib and Mezigdomide in People With Leukemia
被験者募集中第1/2相
- City of Hope Cancer Center (Data collection only), Duarte · 4マイル先
SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
被験者募集中第1相
- City of Hope, Duarte · 4マイル先
Orca-T Following Chemotherapy and Total Marrow and Lymphoid Irradiation for the Treatment of Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia or Myelodysplastic Syndrome
被験者募集中第1相健康なボランティア歓迎
- City of Hope Medical Center, Duarte · 4マイル先
Study of Talazoparib in Combination With Chemotherapy in Relapsed Pediatric AML to Determine Safety and Efficacy
被験者募集中第1相
- City of Hope, Duarte · 4マイル先
A Study of GLB-001 in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher Risk Myelodysplastic Syndromes
被験者募集中第1相
- City of Hope Medical Center, Duarte · 4マイル先
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
被験者募集中第2相
- City of Hope, Duarte · 4マイル先
A Study of CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias
被験者募集中第1相
- City of Hope, Duarte · 4マイル先
CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant
被験者募集中第2相健康なボランティア歓迎
- City of Hope Medical Center, Duarte · 4マイル先
CD33-CAR T Cell Therapy for the Treatment of Recurrent or Refractory Acute Myeloid Leukemia
被験者募集中第1相
- City of Hope Medical Center, Duarte · 4マイル先
Olutasidenib for the Treatment of Patients With IDH1 Mutated AML, MDS or CMML After Donor Hematopoietic Cell Transplant
被験者募集中第1相
- City of Hope Medical Center, Duarte · 4マイル先
Revumenib for the Treatment of Acute Leukemia in Patients Post-Allogeneic Stem Cell Transplant
被験者募集中第1相
- City of Hope Medical Center, Duarte · 4マイル先
Safety of MT-401-OTS in Patients With Relapsed AML or MDS
被験者募集中第1相
- City of Hope Center (City of Hope National Medical Center, City of Hope Medical Center), Duarte · 4マイル先
Ruxolitinib With Tacrolimus and Methotrexate for the Prevention of Graft Versus Host Disease in Pediatric and Young Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome
被験者募集中第2相
- City of Hope Medical Center, Duarte · 4マイル先
Study of NMS-03597812 in Adult Patients With Relapsed/Refractory Acute Myeloid Leukemia
被験者募集中第1相
- City of Hope - Duarte, Duarte · 4マイル先
A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome
被験者募集中第1相
- City of Hope Medical Center, Duarte · 4マイル先
Study of REM-422 in Patients With AML or Higher Risk MDS
被験者募集中第1相
- City of Hope, Duarte · 4マイル先
A Study of BTX-A51 in People With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
被験者募集中第1相
- City of Hope National Medical Center, Duarte · 4マイル先
他の都市における急性骨髄性白血病の試験
- Houston, TX85件の研究
- New York City, NY51件の研究
- Boston, MA44件の研究
- Seattle, WA41件の研究
- Columbus, OH35件の研究
- Philadelphia, PA34件の研究
- Durham, NC33件の研究
- Atlanta, GA31件の研究
- Tampa, FL29件の研究
- Chicago, IL26件の研究
- Portland, OR25件の研究
- Washington, DC24件の研究
Baldwin Parkにおける他の研究
- 乳がん44件の研究
- 大腸癌37件の研究
- 非小細胞肺癌36件の研究
- がん（全種類）34件の研究
- 前立腺がん30件の研究
- 転移性癌30件の研究
- 骨髄異形成症候群26件の研究
- 卵巣がん25件の研究
- 肺がん24件の研究
- 多発性骨髄腫23件の研究
- 胃癌22件の研究
- 急性リンパ性白血病21件の研究
ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。